Corticosteroid Hormones and Signal Specificity

J. Funder

DOI: https://doi.org/10.1111/j.1749-6632.1994.tb39202.x

IF: 6.499

1994-11-01

Annals of the New York Academy of Sciences

Abstract:When the human mineralocorticoid receptor was first cloned by Arriza et al.,] it was shown to be expressed at high levels in the hippocampus, and to have indistinguishably high affinity for aldosterone, corticosterone and cortisol. That renal mineralocorticoid receptors and ‘corticosterone-prefering sites’ in the rat hippocampus have identical affinity for a range of steroids had been demonstrated some years before;2 taken together, these studies posed two questions. The first of these-the function and roles of ‘mineralocorticoid receptors’ in nonepithelial tissues such as hippocampus-is the principal subject of this paper. The second, given the much higher circulating levels of cortisollcorticosterone, is how aldosterone can occupy and activate mineralocorticoid receptors in Na+ transporting epithelia. The second of these questions has been answered, at least in part, by the demonstration of the operation of the enzyme lip-hydroxysteroid dehydrogenase in tissues such as kidney and color^.^.^ Subsequent studies exploring the physiological roles of the enzyme in the kidney showed that mineralocorticoid specificity resides neither with the receptor nor the hormone response element. In these studies adrenalectomized rats were given carbonexolone, to block the action of 1 lp-hydroxysteroid dehydrogenase, and the urinary electrolyte effects of corticosterone, or the selective glucocorticoid agonist RU28362, determined.5 Under these conditions both RU28362 and corticosterone produced an effect on urinary electrolytes indistinguishable from that of aldosterone. In addition, the effect of corticosterone was not blocked by either RU486, the glucocorticoid receptor antagonist, or RU28318, the selective mineralocorticoid receptor antagonist, when either were given alone; given together, however, they completely reversed the urinary electrolyte effects of corticosterone. We have interpreted these data as follows. First, in epithelial tissues mineralocorticoid receptors are ‘protected’ by 11 p-hydroxysteroid dehydrogenase. Second, corticosterone is a mineralocorticoid receptor agonist, in that it can product Na+ retention when glucocorticoid receptors are blocked. Third, glucocorticoid receptors also appear able to produce a benchmark mineralocorticoid effect on urinary electrolytes, occupied either by RU28362 or corticosterone in the presence of RU28318. Finally, given the apparently indistinguishable effects of mineralocorticoid and glucocorticoid receptor activation on urinary electrolyte ratios, it would seem most probable that their effects are mediated via relatively simple hormone response elements. Such response elements, of the kind represented by the consensus sequence GGAACAnnnTGTTm, are classically unable to discriminate between activated glucocorticoid receptors, mineralocorticoid receptors, progesterone receptors and androgen receptors. This is clearly not the case in nonepithelial tissues. There are a number of studies which might be chosen to illustrate this difference, for instance on synapsin6 or serotonin 5HT la receptor^;'.^ for this presentation the example chosen is that of the